CUSIP: 23254L603
Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,641,772
-
Share change
-
+1,052,421
-
Total reported value
-
$12,821,791
-
Price per share
-
$7.81
-
Number of holders
-
14
-
Value change
-
+$8,875,010
-
Number of buys
-
9
-
Number of sells
-
4
Quarterly Holders Quick Answers
What is CUSIP 23254L603?
CUSIP 23254L603 identifies CYCC - CYCLACEL PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2021
-
Previous quarter:
Q3 2020
Recent filing periods for CUSIP 23254L603:
Institutional Holders of CYCLACEL PHARMACEUTICALS INC - COM (CYCC) as of Q4 2020
As of 31 Dec 2020,
CYCLACEL PHARMACEUTICALS INC - COM (CYCC) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,641,772 shares.
The largest 10 holders included
PURA VIDA INVESTMENTS, LLC, Ikarian Capital, LLC, COMMODORE CAPITAL LP, Acuta Capital Partners, LLC, Affinity Asset Advisors, LLC, MORGAN STANLEY, Raymond James Financial Services Advisors, Inc., BOOTHBAY FUND MANAGEMENT, LLC, VANGUARD GROUP INC, and Virtu Financial LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.